Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 10 2019
Historique:
received: 11 04 2019
accepted: 23 09 2019
entrez: 19 10 2019
pubmed: 19 10 2019
medline: 25 1 2020
Statut: epublish

Résumé

Infections by multidrug-resistant bacteria (MDRB) remain a leading cause of morbidity and mortality after liver transplantation (LT). Gut dysbiosis characteristic of end-stage liver disease may predispose patients to intestinal MDRB colonization and infection, in turn exacerbating dysbiosis. However, relationships between MDRB colonization and dysbiosis after LT remain unclear. We prospectively recruited 177 adult patients undergoing LT at a single tertiary care center. 16 S V3-V4 rRNA sequencing was performed on 723 fecal samples collected pre-LT and periodically until one-year post-LT to test whether MDRB colonization was associated with decreased microbiome diversity. In multivariate linear mixed-effect models, MDRB colonization predicts reduced Shannon α-diversity, after controlling for underlying liver disease, antibiotic exposures, and clinical complications. Importantly, pre-LT microbial markers predict subsequent colonization by MDRB. Our results suggest MDRB colonization as a major, previously unrecognized, marker of persistent dysbiosis. Therapeutic approaches accounting for microbial and clinical factors are needed to address post-transplant microbiome health.

Identifiants

pubmed: 31624266
doi: 10.1038/s41467-019-12633-4
pii: 10.1038/s41467-019-12633-4
pmc: PMC6797753
doi:

Substances chimiques

Anti-Bacterial Agents 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4715

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI116939
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001875
Pays : United States

Références

Nucleic Acids Res. 2013 Jan 7;41(1):e1
pubmed: 22933715
Ann Hepatol. 2006 Apr-Jun;5(2):77-85
pubmed: 16807513
Sci Rep. 2017 Jun 19;7(1):3762
pubmed: 28630433
Clin Microbiol Infect. 2014 Sep;20 Suppl 7:49-73
pubmed: 24861521
Microb Ecol Health Dis. 2015 May 29;26:27663
pubmed: 26028277
Genome Biol. 2004;5(10):R80
pubmed: 15461798
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):10467-10472
pubmed: 28900004
Dig Dis. 2011;29(6):518-24
pubmed: 22179206
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Am J Physiol. 1998 Dec;275(6):G1252-8
pubmed: 9843760
Clin Infect Dis. 2017 May 1;64(9):1147-1153
pubmed: 28402408
Drug Metab Dispos. 2019 Mar;47(3):194-202
pubmed: 30598508
Eur J Gastroenterol Hepatol. 1999 Apr;11(4):409-12
pubmed: 10321758
Liver Int. 2018 Jan;38(1):50-58
pubmed: 28561276
Lancet. 2016 Jan 16;387(10015):285-95
pubmed: 26603921
Nature. 2014 Sep 4;513(7516):59-64
pubmed: 25079328
Clin Infect Dis. 2018 Aug 31;67(6):905-912
pubmed: 29718144
Am J Infect Control. 2011 Aug;39(6):506-10
pubmed: 21492962
Sci Transl Med. 2012 Jun 6;4(137):137rv5
pubmed: 22674555
Transpl Infect Dis. 2015 Apr;17(2):174-84
pubmed: 25728703
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Microbiome. 2017 Mar 3;5(1):27
pubmed: 28253908
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Rev Microbiol. 2017 Oct;15(10):630-638
pubmed: 28626231
Hepatobiliary Surg Nutr. 2013 Jun;2(3):142-7
pubmed: 24570932
PLoS One. 2010 Mar 24;5(3):e9836
pubmed: 20352091
Ann Epidemiol. 2016 Nov;26(11):810-815
pubmed: 27751631
J Stat Softw. 2016;75:
pubmed: 32655332
Liver Transpl. 2015 Dec;21(12):1511-9
pubmed: 26136397
Transplant Direct. 2017 Mar 10;3(4):e144
pubmed: 28405600
Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G966-78
pubmed: 22241860
BMC Gastroenterol. 2014 Feb 24;14:40
pubmed: 24564202
J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S25-7
pubmed: 26447960
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1433-8
pubmed: 26905904
Aliment Pharmacol Ther. 2009 Jun 15;29(12):1273-81
pubmed: 19302262
Cell. 2004 Jul 23;118(2):229-41
pubmed: 15260992
Am J Transplant. 2005 Jan;5(1):125-30
pubmed: 15636620
Antimicrob Agents Chemother. 2009 Oct;53(10):4264-9
pubmed: 19667289
Hepatology. 2011 Aug;54(2):562-72
pubmed: 21574172
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
Hepatology. 2014 Mar;59(3):1144-65
pubmed: 24716201
Clin Infect Dis. 2018 Aug 31;67(6):869-877
pubmed: 29718124
Gut. 2018 Mar;67(3):534-541
pubmed: 28213609
J Hepatol. 1991 Mar;12(2):162-9
pubmed: 2050995
Infect Immun. 2012 Jan;80(1):62-73
pubmed: 22006564
Hepatology. 2013 Feb;57(2):601-9
pubmed: 23055155
Clin Infect Dis. 2019 Aug 1;69(4):604-613
pubmed: 30383203
Trends Immunol. 2005 Jun;26(6):326-33
pubmed: 15922949
Am J Surg. 2011 Apr;201(4):498-502
pubmed: 20619394
Clin Gastroenterol Hepatol. 2015 Sep;13(9):1567-74.e3; quiz e143-4
pubmed: 26044318
Liver Transpl. 2016 May;22(5):579-81
pubmed: 26934673
Microb Ecol. 2013 Apr;65(3):781-91
pubmed: 23504024

Auteurs

Medini K Annavajhala (MK)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.
Microbiome and Pathogen Genomics Core, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.

Angela Gomez-Simmonds (A)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.

Nenad Macesic (N)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Sean B Sullivan (SB)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.
Microbiome and Pathogen Genomics Core, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.

Anna Kress (A)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.

Sabrina D Khan (SD)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.
Microbiome and Pathogen Genomics Core, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.

Marla J Giddins (MJ)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.
Microbiome and Pathogen Genomics Core, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.

Stephania Stump (S)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.
Microbiome and Pathogen Genomics Core, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA.

Grace I Kim (GI)

Division of Digestive and Liver Diseases, Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, NY Presbyterian Hospital, New York, NY, USA.

Ryan Narain (R)

Division of Digestive and Liver Diseases, Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, NY Presbyterian Hospital, New York, NY, USA.

Elizabeth C Verna (EC)

Division of Digestive and Liver Diseases, Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, NY Presbyterian Hospital, New York, NY, USA.

Anne-Catrin Uhlemann (AC)

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA. au2110@cumc.columbia.edu.
Microbiome and Pathogen Genomics Core, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA. au2110@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH